Home > Insider Trading > Filing (0001209191-21-026826)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1637715	Reneo Pharmaceuticals Inc.	RPHM	Pharmaceutical Preparations (2834)	472309515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1780235	Niall O'donnell	C/O Reneo Pharmaceuticals, Inc. 12230 El Camino Real, Suite 230 San Diego CA 92130		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-13	1,034,600	$0.00	1,034,600	No	4	C	Indirect	By RiverVest Venture Fund IV, L.P.
Common Stock	Acquisiton	2021-04-13	829,113	$0.00	1,863,713	No	4	C	Indirect	By RiverVest Venture Fund IV, L.P.
Common Stock	Acquisiton	2021-04-13	200,000	$15.00	2,063,713	No	4	P	Indirect	By RiverVest Venture Fund IV, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By RiverVest Venture Fund IV, L.P.
No	4	C	Indirect	By RiverVest Venture Fund IV, L.P.
No	4	P	Indirect	By RiverVest Venture Fund IV, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2021-04-13	4,629,630	$0.00	1,034,600	$0.00
Common Stock	Series B Preferred Stock	Disposition	2021-04-13	3,710,116	$0.00	829,113	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

All outstanding shares of Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering, for no additional consideration at a rate of 1 share of Common Stock for each 4.4748 shares of Preferred Stock. The Preferred Stock had no expiration date.
The shares held by RiverVest Venture Fund IV, L.P. ("RiverVest Fund IV") are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and the Reporting Person. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers (including the Reporting Person) share voting and dispositive power with regard to the Company's securities directly held by RiverVest Fund IV.
The shares were purchased in the Issuer's initial public offering.